William Johnson, MD
Sports Medicine · la Place, LANPI 1619985819
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $672 of the $1,057 with a category attached, or 63.6%. 6 manufacturers reported payments, led by Johnson & Johnson at 59.4% of the total. Reporting peaked in 2019 at $669 and has fallen 88.8% since, to $75 in 2025. That places this record below the midpoint for sports medicine clinicians in LA, where the typical reported total is $3,045.
Across 39 payments — averaging $27.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$628
- Amgen$182
- Medical Device Business Services, Inc.$118
- Pacira Pharmaceuticals Incorporated$73
- Pacira Therapeutics, Inc.$39
- Mallinckrodt Hospital Products Inc.$18
What the payments were for
- Travel & lodging$38536%
- Food & beverage$67264%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $628 |
| Amgen | 13 | $182 |
| Medical Device Business Services, Inc. | 3 | $118 |
| Pacira Pharmaceuticals Incorporated | 5 | $73 |
| Pacira Therapeutics, Inc. | 3 | $39 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,057 in reported general payments places this provider in the 35th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 149 | $1,693 |
| Diclofenac Sodium | 94 | $1,436 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 171 | $1,382 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 149 | $1,375 |
| Methocarbamol | 54 | $794 |
| Cyclobenzaprine Hcl | 26 | $692 |
| Pregabalin | 83 | $503 |
| Meloxicam | 192 | $465 |
| Celecoxib | 22 | $462 |
| Tramadol Hcl | 95 | $319 |
| Naproxen | 16 | $229 |
| Methylprednisolone | 13 | $101 |
| Alendronate Sodium | 18 | $74 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in la Place
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brett CascioLake Charles$82K
- Brian GodshawNew Orleans$69K
- Andrew GottschalkJefferson$45K
- Michael LeddyAlexandria$44K
- Steven JonesHammond$38K
- Mario Lobao GoncalvesShreveport$32K
- Jeremy BurnhamBaton Rouge$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.